BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22308467)

  • 1. Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema.
    Lucas R; Sridhar S; Rick FG; Gorshkov B; Umapathy NS; Yang G; Oseghale A; Verin AD; Chakraborty T; Matthay MA; Zemskov EA; White R; Block NL; Schally AV
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2084-9. PubMed ID: 22308467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction.
    Czikora I; Sridhar S; Gorshkov B; Alieva IB; Kasa A; Gonzales J; Potapenko O; Umapathy NS; Pillich H; Rick FG; Block NL; Verin AD; Chakraborty T; Matthay MA; Schally AV; Lucas R
    Front Physiol; 2014; 5():259. PubMed ID: 25076911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability.
    Lucas R; Yang G; Gorshkov BA; Zemskov EA; Sridhar S; Umapathy NS; Jezierska-Drutel A; Alieva IB; Leustik M; Hossain H; Fischer B; Catravas JD; Verin AD; Pittet JF; Caldwell RB; Mitchell TJ; Cederbaum SD; Fulton DJ; Matthay MA; Caldwell RW; Romero MJ; Chakraborty T
    Am J Respir Cell Mol Biol; 2012 Oct; 47(4):445-53. PubMed ID: 22582175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Sodium Channel-α Mediates the Protective Effect of the TNF-Derived TIP Peptide in Pneumolysin-Induced Endothelial Barrier Dysfunction.
    Czikora I; Alli AA; Sridhar S; Matthay MA; Pillich H; Hudel M; Berisha B; Gorshkov B; Romero MJ; Gonzales J; Wu G; Huo Y; Su Y; Verin AD; Fulton D; Chakraborty T; Eaton DC; Lucas R
    Front Immunol; 2017; 8():842. PubMed ID: 28785264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation.
    Czikora I; Alli A; Bao HF; Kaftan D; Sridhar S; Apell HJ; Gorshkov B; White R; Zimmermann A; Wendel A; Pauly-Evers M; Hamacher J; Garcia-Gabay I; Fischer B; Verin A; Bagi Z; Pittet JF; Shabbir W; Lemmens-Gruber R; Chakraborty T; Lazrak A; Matthay MA; Eaton DC; Lucas R
    Am J Respir Crit Care Med; 2014 Sep; 190(5):522-32. PubMed ID: 25029038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-review: novel therapeutic strategies to blunt actions of pneumolysin in the lungs.
    Lucas R; Czikora I; Sridhar S; Zemskov E; Gorshkov B; Siddaramappa U; Oseghale A; Lawson J; Verin A; Rick FG; Block NL; Pillich H; Romero M; Leustik M; Schally AV; Chakraborty T
    Toxins (Basel); 2013 Jul; 5(7):1244-60. PubMed ID: 23860351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
    Mezey G; Treszl A; Schally AV; Block NL; Vízkeleti L; Juhász A; Klekner A; Nagy J; Balázs M; Halmos G; Bognár L
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1641-9. PubMed ID: 24878932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue inhibitor of metalloproteinases 3-dependent microvascular endothelial cell barrier function is disrupted under septic conditions.
    Arpino V; Mehta S; Wang L; Bird R; Rohan M; Pape C; Gill SE
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1455-67. PubMed ID: 26993226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas.
    Chatzistamou I; Volakaki AA; Schally AV; Kiaris H; Kittas C
    Regul Pept; 2008 Apr; 147(1-3):33-6. PubMed ID: 18255167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia.
    Witzenrath M; Gutbier B; Hocke AC; Schmeck B; Hippenstiel S; Berger K; Mitchell TJ; de los Toyos JR; Rosseau S; Suttorp N; Schütte H
    Crit Care Med; 2006 Jul; 34(7):1947-54. PubMed ID: 16715037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell Piezo1 mediates pressure-induced lung vascular hyperpermeability via disruption of adherens junctions.
    Friedrich EE; Hong Z; Xiong S; Zhong M; Di A; Rehman J; Komarova YA; Malik AB
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12980-12985. PubMed ID: 31186359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.
    Christodoulou C; Schally AV; Chatzistamou I; Kondi-Pafiti A; Lamnissou K; Kouloheri S; Kalofoutis A; Kiaris H
    Regul Pept; 2006 Sep; 136(1-3):105-8. PubMed ID: 16781787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers.
    Chatzistamou I; Schally AV; Kiaris H; Politi E; Varga J; Kanellis G; Kalofoutis A; Pafiti A; Koutselini H
    Eur J Endocrinol; 2004 Sep; 151(3):391-6. PubMed ID: 15362970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
    Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of growth hormone-releasing hormone signaling is associated with sleep alterations in the dwarf rat.
    Obál F; Fang J; Taishi P; Kacsóh B; Gardi J; Krueger JM
    J Neurosci; 2001 Apr; 21(8):2912-8. PubMed ID: 11306643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.
    Knippenberg S; Ueberberg B; Maus R; Bohling J; Ding N; Tort Tarres M; Hoymann HG; Jonigk D; Izykowski N; Paton JC; Ogunniyi AD; Lindig S; Bauer M; Welte T; Seeger W; Guenther A; Sisson TH; Gauldie J; Kolb M; Maus UA
    Thorax; 2015 Jul; 70(7):636-46. PubMed ID: 25964315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
    Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
    Halmos G; Schally AV; Czompoly T; Krupa M; Varga JL; Rekasi Z
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4707-14. PubMed ID: 12364462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation.
    Bewley MA; Naughton M; Preston J; Mitchell A; Holmes A; Marriott HM; Read RC; Mitchell TJ; Whyte MK; Dockrell DH
    mBio; 2014 Oct; 5(5):e01710-14. PubMed ID: 25293758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.